DigestRedComo funciona
Red
/
Empresas
Me
No verificado

Median Technologies

Sobre qué escribimos

BiotecnologíaMaterial médico sanitarioOncologíaSaludTécnica

37 Comunicados de prensa

Ver todos los comunicados de prensa
02/03/2026
Ferias y Congresos
Industria
Eventos
Biotecnología
Técnica
Sanidad
Salud
Medicina nuclear
Farmacéutica
Oncología
Tecnología
Material médico sanitario
Software
Median Technologies to Showcase eyonis® LCS, Its AI/ML-based Software as a Medical Device for Lung Cancer Screening, at the European Congress of Radiology
Fuente
Median Technologies
Editor
Business Wire
1.00
0
27/02/2026
Eventos
Web y redes sociales
Técnica
Material médico sanitario
Software
Biotecnología
Salud
Farmacéutica
Oncología
Median Technologies to present at the TD Cowen 46th Annual Health Care Conference
Fuente
Median Technologies
Editor
Business Wire
1.00
0
23/02/2026
Web y redes sociales
Industria
Técnica
Higiene alimentaria
Software
Biotecnología
Medicina nuclear
Farmacéutica
Salud
Oncología
Median Technologies to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis® LCS
Fuente
Median Technologies
Editor
Business Wire
1.00
0
18/02/2026
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
Fuente
Median Technologies
Editor
Business Wire
1.00
0
12/02/2026
Mercado laboral
Industria
Técnica
Material médico sanitario
Higiene alimentaria
Software
Biotecnología
Medicina nuclear
Salud
Oncología
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States
Fuente
Median Technologies
Editor
Business Wire
1.00
0
09/02/2026
Industria
Software
Medicina nuclear
Farmacéutica
Oncología
Material médico sanitario
Técnica
Medicina - Varios
Biotecnología
Higiene alimentaria
Salud
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening
Fuente
Median Technologies
Editor
Business Wire
1.00
0
19/01/2026
Software
Medicina nuclear
Farmacéutica
Oncología
Material médico sanitario
Técnica
Medicina - Varios
Biotecnología
Higiene alimentaria
Salud
Industria
Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026
Fuente
Median Technologies
Editor
Business Wire
1.00
0
08/12/2025
Mercado laboral
Industria
Material médico sanitario
Salud
Medicina nuclear
Oncología
Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis® LCS to Patients Across the U.S. and Europe
Fuente
Median Technologies
Editor
Business Wire
1.00
0
25/11/2025
Industria
Eventos
Técnica
Material médico sanitario
Tecnología
Software
Sanidad
Biotecnología
Farmacéutica
Salud
Oncología
Median Technologies to Showcase AI-Powered Software as a Medical Device eyonis® LCS for Lung Cancer Screening at the RSNA 2025 Annual Meeting
Fuente
Median Technologies
Editor
Business Wire
1.00
0
03/11/2025
Software
Biotecnología
Oncología
Salud
Material médico sanitario
Técnica
Mercado laboral
Median Technologies Appoints Didric Cederholm to Its Board of Directors
Fuente
Median Technologies
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0